Page last updated: 2024-09-05

erlotinib hydrochloride and entecavir

erlotinib hydrochloride has been researched along with entecavir in 1 studies

Compound Research Comparison

Studies (erlotinib hydrochloride)	Trials (erlotinib hydrochloride)	Recent Studies (post-2010) (erlotinib hydrochloride)	Studies (entecavir)	Trials (entecavir)	Recent Studies (post-2010) (entecavir)
4,353	786	3,033	1,860	248	1,424

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hu, YQ; Meyer, S; Moyo, H; Tomlinson, C; Waterhouse, C	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and entecavir

Article	Year
How patent law reform can improve affordability and accessibility of medicines in South Africa: Four medicine case studies. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2019, May-31, Volume: 109, Issue:6 Topics: Antineoplastic Agents; Antiviral Agents; Costs and Cost Analysis; Drug Costs; Drug Industry; Erlotinib Hydrochloride; Guanine; Health Services Accessibility; Humans; Immunologic Factors; Lenalidomide; Patents as Topic; Pharmaceutical Preparations; Sorafenib; South Africa	2019

Article

Year

How patent law reform can improve affordability and accessibility of medicines in South Africa: Four medicine case studies.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2019, May-31, Volume: 109, Issue:6

Topics: Antineoplastic Agents; Antiviral Agents; Costs and Cost Analysis; Drug Costs; Drug Industry; Erlotinib Hydrochloride; Guanine; Health Services Accessibility; Humans; Immunologic Factors; Lenalidomide; Patents as Topic; Pharmaceutical Preparations; Sorafenib; South Africa

2019